Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1965 1
1966 1
1967 2
1969 3
1970 3
1971 8
1972 1
1973 1
1974 5
1975 5
1976 5
1977 2
1978 9
1979 5
1980 6
1981 5
1982 6
1983 7
1984 15
1985 22
1986 11
1987 21
1988 34
1989 32
1990 38
1991 47
1992 43
1993 53
1994 54
1995 52
1996 59
1997 46
1998 53
1999 60
2000 68
2001 63
2002 68
2003 78
2004 103
2005 101
2006 107
2007 73
2008 97
2009 110
2010 114
2011 118
2012 120
2013 118
2014 142
2015 126
2016 128
2017 139
2018 106
2019 126
2020 111
2021 126
2022 112
2023 105
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

3,018 results

Results by year

Filters applied: . Clear all
Page 1
Moyamoya disease: diagnosis and interventions.
Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, Yoshimoto T, Miyawaki S, Clausen T, Bang OY, Steinberg GK, Tournier-Lasserve E, Koizumi A. Ihara M, et al. Lancet Neurol. 2022 Aug;21(8):747-758. doi: 10.1016/S1474-4422(22)00165-X. Epub 2022 May 20. Lancet Neurol. 2022. PMID: 35605621 Review.
Moyamoya disease is a rare cause of stroke, radiologically characterised by progressive stenosis of the terminal portion of the internal carotid arteries and compensatory capillary collaterals. The discovery that RNF213, which encodes an unconventional E3 ubiquitin ligase, …
Moyamoya disease is a rare cause of stroke, radiologically characterised by progressive stenosis of the terminal portion of the inter …
CNS small vessel disease: A clinical review.
Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF. Cannistraro RJ, et al. Neurology. 2019 Jun 11;92(24):1146-1156. doi: 10.1212/WNL.0000000000007654. Epub 2019 May 29. Neurology. 2019. PMID: 31142635 Free PMC article. Review.
CNS small vessel disease (CSVD) causes 25% of strokes and contributes to 45% of dementia cases. ...Known causes and risk factors include age, hypertension, branch atheromatous disease, cerebral amyloid angiopathy, radiation exposure, immune-mediated vasculiti …
CNS small vessel disease (CSVD) causes 25% of strokes and contributes to 45% of dementia cases. ...Known causes and risk factors incl …
CADASIL.
Wang MM. Wang MM. Handb Clin Neurol. 2018;148:733-743. doi: 10.1016/B978-0-444-64076-5.00047-8. Handb Clin Neurol. 2018. PMID: 29478611 Review.
Cerebral small-vessel disease is a prevalent condition that is strongly associated with ischemic stroke and dementia. The most prevalent inherited cause of cerebral small-vessel disease is CADASIL, cerebral autosomal-dominant arteriopathy with s
Cerebral small-vessel disease is a prevalent condition that is strongly associated with ischemic stroke and dementia. The most
Moyamoya disease and moyamoya syndrome.
Scott RM, Smith ER. Scott RM, et al. N Engl J Med. 2009 Mar 19;360(12):1226-37. doi: 10.1056/NEJMra0804622. N Engl J Med. 2009. PMID: 19297575 Review. No abstract available.
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.
Zhang X, Xiao W, Zhang Q, Xia D, Gao P, Su J, Yang H, Gao X, Ni W, Lei Y, Gu Y. Zhang X, et al. Curr Neuropharmacol. 2022;20(2):292-308. doi: 10.2174/1570159X19666210716114016. Curr Neuropharmacol. 2022. PMID: 34279201 Free PMC article. Review.
Moyamoya disease (MMD) is a chronic cerebrovascular disease characterized by progressive stenosis of the arteries of the circle of Willis, with the formation of collateral vascular network at the base of the brain. ...At present, the main treatment for MMD focuses o …
Moyamoya disease (MMD) is a chronic cerebrovascular disease characterized by progressive stenosis of the arteries of the circl …
Progress in moyamoya disease.
Shang S, Zhou D, Ya J, Li S, Yang Q, Ding Y, Ji X, Meng R. Shang S, et al. Neurosurg Rev. 2020 Apr;43(2):371-382. doi: 10.1007/s10143-018-0994-5. Epub 2018 Jun 18. Neurosurg Rev. 2020. PMID: 29911252 Review.
Moyamoya disease is characterized by progressive stenosis or occlusion of the intracranial portion of the internal carotid artery and their proximal branches, resulting in ischemic or hemorrhagic stroke with high rate of disability and even death. So far, available treatme …
Moyamoya disease is characterized by progressive stenosis or occlusion of the intracranial portion of the internal carotid artery and …
Emerging concepts in sporadic cerebral amyloid angiopathy.
Charidimou A, Boulouis G, Gurol ME, Ayata C, Bacskai BJ, Frosch MP, Viswanathan A, Greenberg SM. Charidimou A, et al. Brain. 2017 Jul 1;140(7):1829-1850. doi: 10.1093/brain/awx047. Brain. 2017. PMID: 28334869 Free PMC article. Review.
Sporadic cerebral amyloid angiopathy is a common, well-defined small vessel disease and a largely untreatable cause of intracerebral haemorrhage and contributor to age-related cognitive decline. The term 'cerebral amyloid angiopathy' now encompasses not only …
Sporadic cerebral amyloid angiopathy is a common, well-defined small vessel disease and a largely untreatable cause of intrace …
Moyamoya Disease: A Review of Clinical Research.
Hishikawa T, Sugiu K, Date I. Hishikawa T, et al. Acta Med Okayama. 2016 Aug;70(4):229-36. doi: 10.18926/AMO/54497. Acta Med Okayama. 2016. PMID: 27549666 Free article. Review.
About 5 decades have passed since the concept of moyamoya disease (MMD) was established in Japan. In that time, many clinical MMD studies have been performed from several different points of view, such as epidemiology, pathophysiology, surgical procedures, and prognosis. . …
About 5 decades have passed since the concept of moyamoya disease (MMD) was established in Japan. In that time, many clinical MMD stu …
Current treatment for childhood arterial ischaemic stroke.
Sporns PB, Fullerton HJ, Lee S, Kirton A, Wildgruber M. Sporns PB, et al. Lancet Child Adolesc Health. 2021 Nov;5(11):825-836. doi: 10.1016/S2352-4642(21)00167-X. Epub 2021 Jul 29. Lancet Child Adolesc Health. 2021. PMID: 34331864 Review.
Paediatric arterial ischaemic stroke is an important cause of neurological morbidity in children, with consequences including motor disorders, intellectual impairment, and epilepsy. The causes of paediatric arterial ischaemic stroke are unique compared with those as …
Paediatric arterial ischaemic stroke is an important cause of neurological morbidity in children, with consequences including motor d …
CADASIL: new advances in basic science and clinical perspectives.
Ferrante EA, Cudrici CD, Boehm M. Ferrante EA, et al. Curr Opin Hematol. 2019 May;26(3):193-198. doi: 10.1097/MOH.0000000000000497. Curr Opin Hematol. 2019. PMID: 30855338 Free PMC article. Review.
Despite improved diagnosis, the disease mechanism remains an elusive target and an increasing number of scientific/clinical groups are investigating CADASIL to better understand it. ...NOTCH3 mutation locations are highly variable, correlate to disease severity and …
Despite improved diagnosis, the disease mechanism remains an elusive target and an increasing number of scientific/clinical groups ar …
3,018 results